Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Clinical trial NCT02228421 · TERMINATED

Trial details

NCT number: NCT02228421
Sponsor: PeriPharm
Status: TERMINATED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Metastatic

Start date: 2015-02-01
Primary completion: 2020-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.